Integration of Signage Information into the Web Environment

Rashad Aouf,Steve Hansen

DOI: https://doi.org/10.1007/978-3-540-27817-7_158

2004-07-07

Abstract:

What problem does this paper attempt to address?

A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors

Xiaojia Huang,Kai Xiao Xia,Meiling Yang,Mengzhi Xiao Hong,Meihua Xiao Jiang,Weiqiang Li,Zhenmin Lei,Andy Peng Xiang,Wei Zhao

DOI: https://doi.org/10.1101/2024.08.02.606288

2024-08-06

Abstract:The declining rates of male fertility pose a significant clinical challenge, primarily due to our limited understanding of the testicular interstitium, which is crucial for male reproductive health. Here, we conducted a comprehensive analysis of the single-cell transcriptomic landscape of the murine testicular interstitium across the postnatal lifespan. Our investigation unveiled a previously unrecognized population of Cd34 /Sox4 mesenchymal cells nestled within the interstitium, hinting at their potential as Leydig cell progenitors. During the aging process of Cd34 /Sox4 mesenchymal cells, we observed a decline in glutathione levels within the testicular interstitium. Remarkably, these Cd34 /Sox4 mesenchymal cells exhibited clonogenic self-renewal capacity and an impressive propensity to differentiate into Leydig cells. Intriguingly, when transplanted into Leydig cell-disrupted or failure models, Cd34 /Sox4 cells efficiently colonized the testicular interstitium, resulting in a notable increase in testosterone production. Exploring the epigenetic landscape, we identified critical transcription factors, most notably Sox4, governing the stem cell fate of Cd34 /Sox4 mesenchymal cells. Overall, this comprehensive reference atlas of lifespan testicular Leydig cells presents significant findings that may guide the development of cell-based strategies for treating testicular hypogonadism in elderly individuals.

Developmental Biology
High Throughput scRNA-Seq Provides Insights Into Leydig Cell Senescence Induced by Experimental Autoimmune Orchitis: A Prominent Role of Interstitial Fibrosis and Complement Activation

Yinchuan Li,Panpan Mi,Jiabao Wu,Yunge Tang,Xiaohua Liu,Jinmei Cheng,Yingying Huang,Weibing Qin,C. Yan Cheng,Fei Sun

DOI: https://doi.org/10.3389/fimmu.2021.771373

IF: 7.3

2022-01-17

Frontiers in Immunology

Abstract:Leydig cells (Lc), located in the interstitial space of the testis between seminiferous tubules, produce 95% of testosterone in male individuals, which is pivotal for male sexual differentiation, spermatogenesis, and maintenance of the male secondary sex characteristics. Lc are prone to senescence in aging testes, resulting in compromised androgen synthesis capability upon aging. However, little is known about whether Lc undergo senescence in a chronic inflammatory environment. To investigate this question, mouse models of experimental autoimmune orchitis (EAO) were used, and Lc were analyzed by high throughput scRNA-Seq. Data were screened and analyzed by correlating signaling pathways with senescence, apoptosis, androgen synthesis, and cytokine/chemokine signaling pathways. EAO did induce Lc senescence, and Lc senescence in turn antagonized androgen synthesis. Based on the correlation screening of pathways inducing Lc senescence, a plethora of pathways were found to play potential roles in triggering Lc senescence during EAO, among which the Arf6 and angiopoietin receptor pathways were highly correlated with senescence signature. Notably, complement and interstitial fibrosis activated by EAO worsened Lc senescence and strongly antagonized androgen synthesis. Furthermore, most proinflammatory cytokines enhanced both senescence and apoptosis in Lc and spermatogonia (Sg) during EAO, and proinflammatory cytokine antagonism of the glutathione metabolism pathway may be key in inducing cellular senescence during EAO.

immunology
Stem Leydig cells support macrophage immunological homeostasis through mitochondrial transfer in mice

Ani Chi,Bicheng Yang,Hao Dai,Xinyu Li,Jiahui Mo,Yong Gao,Zhihong Chen,Xin Feng,Menghui Ma,Yanqing Li,Chao Yang,Jie Liu,Hanchao Liu,Zhenqing Wang,Feng Gao,Yan Liao,Xuetao Shi,Chunhua Deng,Min Zhang

DOI: https://doi.org/10.1038/s41467-024-46190-2

IF: 16.6

2024-03-08

Nature Communications

Abstract:Abstract As testicular mesenchymal stromal cells, stem Leydig cells (SLCs) show great promise in the treatment of male hypogonadism. The therapeutic functions of mesenchymal stromal cells are largely determined by their reciprocal regulation by immune responses. However, the immunoregulatory properties of SLCs remain unclear. Here, we observe that SLCs transplantation restore male fertility and testosterone production in an ischemia‒reperfusion injury mouse model. SLCs prevent inflammatory cascades through mitochondrial transfer to macrophages. Reactive oxygen species (ROS) released from activated macrophages inducing mitochondrial transfer from SLCs to macrophages in a transient receptor potential cation channel subfamily member 7 (TRPM7)-mediated manner. Notably, knockdown of TRPM7 in transplanted SLCs compromised therapeutic outcomes in both testicular ischemia‒reperfusion and testicular aging mouse models. These findings reveal a new mechanism of SLCs transplantation that may contribute to preserve testis function in male patients with hypogonadism related to immune disorders.

multidisciplinary sciences
Androgen-Forming Stem Leydig Cells: Identification, Function and Therapeutic Potential

Yunhui Zhang,Renshan Ge,Matthew P. Hardy

DOI: https://doi.org/10.1155/2008/905025

2008-01-01

Disease Markers

Abstract:Leydig cells are the primary source of testosterone in the male, and differentiation of Leydig cells in the testes is one of the primary events in the development of the male body and fertility. Stem Leydig cells (SLCs) exist in the testis throughout postnatal life, but a lack of cell surface markers previously hindered attempts to obtain purified SLC fractions. Once isolated, the properties of SLCs provide interesting clues for the ontogeny of these cells within the embryo. Moreover, the clinical potential of SLCs might be used to reverse age-related declines in testosterone levels in aging men, and stimulate reproductive function in hypogonadal males. This review focuses on the source, identification and outlook for therapeutic applications of SLCs. Separate pools of SLCs may give rise to fetal and adult generations of Leydig cell, which may account for their observed functional differences. These differences should in turn be taken into account when assessing the consequences of environmental pollutants such as the phthalate ester, diethylhexylphthalate (DEHP).
(063) The Role of Leptin as a Testicular Immune Microenvironment Modulator and Leydig Stem Cell Function

A Dullea,K Khodamoradi,D Seetharam,I Issa,R Ramasamy,H Arora

DOI: https://doi.org/10.1093/jsxmed/qdae001.059

2024-02-07

The Journal of Sexual Medicine

Abstract:Introduction The testicular microenvironment, consisting of cells including Sertoli and peritubular cells, releases paracrine factors that may regulate testicular function. In previous research, Leptin was identified as a critical paracrine factor in the testicular microenvironment. Leptin is secreted by Sertoli and peritubular cells and binds to its receptor in Leydig cells. This interaction triggers the expression of the desert hedgehog signaling pathway, which is essential for Leydig stem cell differentiation into adult Leydig cells, which are capable of producing testosterone. However, our earlier study had a limitation: the human cell model used was derived from testes biopsies, lacking an intact immune microenvironment. This study investigates the effect of Leptin on a complete testicular immune microenvironment in a murine model. Objective To investigate the impact of Leptin on a complete testicular immune microenvironment. Methods We used 6-week-old C57BL6 mice, exposed to two different concentrations of Leptin, 10 and 100 mg/ml, for seven days. After the treatment period, the animals were humanely euthanized, and their blood and testes were collected. Blood samples underwent a complete blood count differential profile analysis using a Hemavet Mascot Multispecies Hematology System Counter 1500R. Testes samples were subjected to comprehensive immunophenotyping, allowing us to assess the impact of Leptin treatment on various immune cell types within the testes Results Leptin at a low dose (10 mg/ml) showed increased, but not significant, levels of serum testosterone (13.20 + 0.37 ng/dl), while LH and FSH levels significantly (p<0.05) increased. In contrast, animals receiving 100 mg/ml Leptin showed no significant changes in hormone levels. CBC profiling indicated that lymphocytes and platelets were significantly influenced, specifically with low doses of Leptin. Comprehensive immunophenotyping revealed a significant increase in CD4+ (helper T cells) and CD8+ (cytotoxic T lymphocytes) cell numbers in animals treated with low doses of Leptin, a pattern not observed with high doses. Conclusions This study uncovers previously unexplored aspects of how paracrine factors, released by Sertoli and peritubular myoid cells, can modulate the immune microenvironment within the testis, potentially impacting testosterone production. Future research will investigate the relationship between changes in immune cell types, increased T cell numbers, and their influence on Leydig stem cell differentiation into adult Leydig cells Disclosure No.

urology & nephrology
Calcific aortic valve disease: new concepts.

C. Otto

DOI: https://doi.org/10.1053/j.semtcvs.2011.01.009

IF: 2.41

2010-12-01

Seminars in Thoracic and Cardiovascular Surgery

Abstract:Our understanding of calcific aortic stenosis has changed dramatically during the past 3 decades, with the concept of a "mechanical" disease of aging now replaced by the concept of an active disease process at the tissue level that may be amenable to medical therapy. The ability of echocardiography to provide early diagnosis and an accurate measurement of disease severity has increased our knowledge of the natural history of this disease process and allows us to follow individual patients over time, long before valve replacement is needed. We now recognize that even mild symptoms are an indication for valve replacement when severe obstruction is present. This review discusses the optimal approach to measurement of disease severity, the presymptomatic disease course, and the underlying causes of calcific valve disease, followed by a summary of clinical trials of medical therapy and the current indications and choices for valve replacement.
NR2F2 regulation of interstitial to fetal Leydig cell differentiation in the testis: insights into differences of sex development

Martín Andrés Estermann,Sara Grimm,Abigail Kitakule,Karina Rodriguez,Paula Brown,Kathryn McClelland,Ciro Amato,Humphrey Hung-Chang Yao

DOI: https://doi.org/10.1101/2024.09.16.613312

2024-09-16

Abstract:Testicular fetal Leydig cells are a specialized cell type responsible for embryo masculinization. Fetal Leydig cells produce androgens, that induce the differentiation of male reproductive system and sexual characteristics. Deficiencies in Leydig cell differentiation leads to various disorders of sex development and male reproductive defects such as ambiguous genitalia, hypospadias, cryptorchidism, and infertility. Fetal Leydig cells are thought to originate from proliferating progenitor cells in the testis interstitium, marked by genes like , , and . However, the precise mechanisms governing the transition from interstitial cells to fetal Leydig cells remain elusive. Through integrated approaches involving mouse models and single-nucleus multiomic analyses, we discovered that fetal Leydig cells originate from a -positive non-steroidogenic interstitial cell population. Embryonic deletion of in mouse testes resulted in disorders of sex development, including dysgenic testes, Leydig cell hypoplasia, cryptorchidism, and hypospadias. We found that NR2F2 promotes the progenitor cell fate while suppresses Leydig cell differentiation by directly and indirectly controlling a cohort of transcription factors and downstream genes. Bioinformatic analyses of single-nucleus ATAC-seq and NR2F2 ChIP-seq data revealed putative transcription factors co-regulating the process of interstitial to Leydig cell differentiation. Collectively, our findings not only highlight the critical role of in orchestrating the transition from interstitial cells to fetal Leydig cells, but also provide molecular insight into the disorders of sex development as a result of mutations.

Biology
Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction

Ani Chi,Chao Yang,Jie Liu,Zhichen Zhai,Xuetao Shi

DOI: https://doi.org/10.1002/advs.202410808

IF: 15.1

2024-11-27

Advanced Science

Abstract:Graphical abstract showing the mechanism by which dTECM‐SLC‐based therapy ameliorates testicular LC dysfunction. Local injection of dTECM‐SLC into the testicular interstitium. dTECM creates a favorable microenvironment for SLC proliferation and differentiation. dTECM‐SLC effectively increases testosterone levels and reshapes the local immune microenvironment in the testicular interstitium. After treatment, symptoms associated with testosterone deficiency are ultimately alleviated, as evidenced by increased muscle mass, alleviation of osteoporosis, loss of white fat volume, and improved cognitive function. Therapies involving the use of stem Leydig cells (SLCs), as testicular mesenchymal stromal cells, have shown great promise in the treatment of Leydig cell (LC) dysfunction in aging males. However, the outcomes of these therapies are not satisfactory. In this study, it is demonstrated that the aging microenvironment of the testicular interstitium impairs the function of SLCs, leading to poor regeneration of LCs and, consequently, inefficient functional restoration. The study develops a decellularized testicular extracellular matrix (dTECM) hydrogel from young pigs and evaluates its safety and feasibility as a supportive niche for the expansion and differentiation of SLCs. dTECM hydrogel facilitates the steroidogenic differentiation of SLCs into LCs, the primary producers of testosterone. The combination of SLCs with a dTECM hydrogel leads to a significant and sustained increase in testosterone levels, which promotes the restoration of spermatogenesis and fertility in an LC‐deficient and aged mouse model. Mechanistically, collagen 1 within the dTECM is identified as a key factor contributing to these effects. Notably, symptoms associated with testosterone deficiency syndrome are significantly alleviated in aged mice. These findings may aid the design of therapeutic interventions for patients with testosterone deficiency in the clinic.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency

Zhi Jun Zang,Jiancheng Wang,Zhihong Chen,Yan Zhang,Yong Gao,Zhijian Su,Ying Tuo,Yan Liao,Min Zhang,Qunfang Yuan,Chunhua Deng,Mei Hua Jiang,Andy Peng Xiang

DOI: https://doi.org/10.1002/stem.2569

IF: 5.845

2017-01-01

Stem Cells

Abstract:Stem Leydig cell (SLC) transplantation could provide a new strategy for treating the testosterone deficiency. Our previous study demonstrated that CD51 (also called integrin αv) might be a putative cell surface marker for SLCs, but the physiological function and efficacy of CD51+ SLCs treatment remain unclear. Here, we explore the potential therapeutic benefits of CD51+ SLCs transplantation and whether these transplanted cells can be regulated by the hypothalamic‐pituitary‐gonadal (HPG) axis. CD51+ cells were isolated from the testes of 12‐weeks‐old C57BL/6 mice, and we showed that such cells expressed SLC markers and that they were capable of self‐renewal, extensive proliferation, and differentiation into multiple mesenchymal cell lineages and LCs in vitro. As a specific cytotoxin that eliminates Leydig cells (LCs) in adult rats, ethane dimethanesulfonate (EDS) was used to ablate LCs before the SLC transplantation. After being transplanted into the testes of EDS‐treated rats, the CD51+ cells differentiated into mature LCs, and the recipient rats showed a partial recovery of testosterone production and spermatogenesis. Notably, a testosterone analysis revealed a circadian rhythm of testosterone secretion in cell‐transplanted rats, and these testosterone secretions could be suppressed by decapeptyl (a luteinizing hormone‐releasing hormone agonist), suggesting that the transplanted cells might be regulated by the HPG axis. This study is the first to demonstrate that CD51+ SLCs can restore the neuroendocrine regulation of testicular function by physiologically recovering the expected episodic changes in diurnal testosterone serum levels and that SLC transplantation may provide a new tool for the studies of testosterone deficiency treatment. Stem Cells 2017;35:1222–1232
Effects of aging and macrophages on mice stem Leydig cell proliferation and differentiation in vitro

Jingjing Shao,Jiexia Wang,Xin Wen,Jiajia Xie,Fu Huang,Xiaoju Guan,Xinrui Hao,Ping Duan,Congde Chen,Haolin Chen

DOI: https://doi.org/10.3389/fendo.2023.1139281

IF: 6.055

2023-03-28

Frontiers in Endocrinology

Abstract:Background: Testosterone plays a critical role in maintaining reproductive functions and well-beings of the males. Adult testicular Leydig cells (LCs) produce testosterone and are generated from stem Leydig cells (SLCs) during puberty through adulthood. In addition, macrophages are critical in the SLC regulatory niche for normal testicular function. Age-related reduction in serum testosterone contributes to a number of metabolic and quality-of-life changes in males, as well as age-related changes in immunological functions. How aging and testicular macrophages may affect SLC function is still unclear. Methods: SLCs and macrophages were purified from adult and aged mice via FACS using CD51 as a marker protein. The sorted cells were first characterized and then co-cultured in vitro to examine how aging and macrophages may affect SLC proliferation and differentiation. To elucidate specific aging effects on both cell types, co-culture of sorted SLCs and macrophages were also carried out across two ages. Results: CD51+ (weakly positive) and CD51++ (strongly positive) cells expressed typical SLC and macrophage markers, respectively. However, with aging, both cell types increased expression of multiple cytokine genes, such as IL-1b, IL-6 and IL-8. Moreover, old CD51+ SLCs reduced their proliferation and differentiation, with a more significant reduction in differentiation (2X) than proliferation (30%). Age matched CD51++ macrophages inhibited CD51+ SLC development, with a more significant reduction in old cells (60%) than young (40%). Crossed-age co-culture experiments indicated that the age of CD51+ SLCs plays a more significant role in determining age-related inhibitory effects. In LC lineage formation, CD51+ SLC had both reduced LC lineage markers and increased myoid cell lineage markers, suggesting an age-related lineage shift for SLCs. Conclusion: The results suggest that aging affected both SLC function and their regulatory niche cell, macrophages.

endocrinology & metabolism
An autofluorescence-based isolation of Leydig cells for testosterone deficiency treatment

Peng Luo,Xin Feng,Ronghai Deng,Fulin Wang,Yadong Zhang,Xiangping Li,Min Zhang,Zi Wan,Andy Peng Xiang,Kai Xia,Yong Gao,Chunhua Deng

DOI: https://doi.org/10.1016/j.mce.2021.111389

IF: 4.369

2021-09-01

Molecular and Cellular Endocrinology

Abstract:<p>Effective procedures for the purification of Leydig cells (LCs) can facilitate functional studies and transplantation therapies. However, current methods to purify LCs from testes are still far from satisfactory. Here, we found that testicular autofluorescence existed in the interstitium along with the gradual maturation of LCs from birth to adulthood. These autofluorescent cells were further isolated by fluorescence-activated cell sorting (FACS) and determined to be composed of LCs and macrophages. To further purify LCs, we combined two fluorescence channels of FACS and successfully separated LCs and macrophages. Of note, we confirmed that the obtained LCs not only possessed high purity, viability and quantity but also had intact steroidogenic activity and excellent responsiveness to luteinizing hormone. Moreover, subcutaneous transplantation of isolated LCs could alleviate the symptoms of testosterone deficiency in castrated mice. In summary, we established an effective autofluorescence-based method for isolating LCs. This method will aid in the future success of using LCs for basic and translational applications.</p>

cell biology,endocrinology & metabolism
The Cell Fates of Intermediate Cell Population in Prostate Development

Xiaoyu Zhang,Jian Wang,Wangxin Guo,Hongjiong Zhang,Bin Zhou,Chen Yu,Dong Gao

DOI: https://doi.org/10.1016/j.cellin.2024.100182

2024-01-01

Cell Insight

Abstract:Organ development, regeneration and cancer initiation are typically influenced by the proliferation and lineage plasticity of tissue-specific stem cells. Prostate intermediate cells, which exhibit characteristics of both basal and luminal cells, are prevalent in pathological states and during organ development. However, the identity, fate and function of these intermediate cells in prostate development are not well understood. Through single-cell RNA-seq analysis on neonatal urogenital sinus tissue, we identified intermediate cells exhibiting stem cell potential. A notable decline in the population of intermediate cells was observed during prostate development. Prostate intermediate cells were specifically labeled in early and late postnatal development by the enhanced dual-recombinase-mediated genetic tracing systems. Our findings revealed that these cells possess significant stem cell capabilities as demonstrated in organoid formation and cell fate mapping assays. These intermediate cells also exhibited intrinsic bipotential properties, enabling them to differentiate into both basal and luminal cells. Additionally, we discovered a novel transition from intermediate cell expressing neuroendocrine markers to neuroendocrine cell during prostate development. This study highlights intermediate cells as a crucial stem cell population and enhances our understanding of their role in prostate development and the plasticity of prostate cancer lineage.
Single-Cell RNAseq Resolve the Potential Effects of LanCL1 Gene in the Mouse Testis

Jiangting Lu,Jinling Liao,Min Qin,Hui Li,Qingyuan Zhang,Yang Chen,Jiwen Cheng

DOI: https://doi.org/10.3390/cells11244135

IF: 6

2022-12-20

Cells

Abstract:Infertility affects lots of couples, half of which are caused by male factors. The LanCL1 gene is highly expressed in testis specifically, which might affect the development of sperms. In order to understand the potential functions of the LanCL1 gene in the testis, this study was conducted with constructed transgenic LanCL1 knockout mice. The mouse breeding experiment, semen analysis and single-cell RNAseq of testicular tissue were performed. Results suggested that the LanCL1 gene would significantly influence the reproduction ability and sperm motility of male mice. Single-cell RNAseq also confirmed the high expression of the LanCL1 gene in the spermatocytes and spermatids. Downregulating the LanCL1 gene expression could promote M2 macrophage polarity to maintain testicular homeostasis. Moreover, the LanCL1 gene could affect both the germ cells and stromal cells through various pathways such as the P53 signaling and the PPAR signaling pathway to disturb the normal process of spermatogenesis. However, no effects of the LanCL1 gene in testosterone synthesis and serum testosterone level were shown. Further studies are needed to discuss the mechanisms of the LanCL1 gene in the various cells of the testis independently.

cell biology
Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults.

Mark H. Pinkerton,V. Chinchilli,E. Banta,T. Craig,A. August,R. Bascom,M. Cantorna,E. Harvill,F. Ishmael

DOI: https://doi.org/10.1016/j.jaci.2013.03.006

IF: 14.29

2013-07-01

Journal of Allergy and Clinical Immunology

Abstract:
Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction

Mei Hua Jiang,Bing Cai,Ying Tuo,Jiancheng Wang,Zhi Jun Zang,Xiang'an Tu,Yong Gao,Zhijian Su,Weiqiang Li,Guilan Li,Min Zhang,Jianwei Jiao,Zi Wan,Chunhua Deng,Bruce T Lahn,Andy Peng Xiang

DOI: https://doi.org/10.1038/cr.2014.149

IF: 44.1

2014-11-21

Cell Research

Abstract:The ability to identify and isolate lineage-specific stem cells from adult tissues could facilitate cell replacement therapy. Leydig cells (LCs) are the primary source of androgen in the mammalian testis, and the prospective identification of stem Leydig cells (SLCs) may offer new opportunities for treating testosterone deficiency. Here, in a transgenic mouse model expressing GFP driven by the Nestin (Nes) promoter, we observed Nes-GFP+ cells located in the testicular interstitial compartment where SLCs normally reside. We showed that these Nes-GFP+ cells expressed LIFR and PDGFR-α, but not LC lineage markers. We further observed that these cells were capable of clonogenic self-renewal and extensive proliferation in vitro and could differentiate into neural or mesenchymal cell lineages, as well as LCs, with the ability to produce testosterone, under defined conditions. Moreover, when transplanted into the testes of LC-disrupted or aging models, the Nes-GFP+ cells colonized the interstitium and partially increased testosterone production, and then accelerated meiotic and post-meiotic germ cell recovery. In addition, we further demonstrated that CD51 might be a putative cell surface marker for SLCs, similar with Nestin. Taken together, these results suggest that Nes-GFP+ cells from the testis have the characteristics of SLCs, and our study would shed new light on developing stem cell replacement therapy for testosterone deficiency.

cell biology
Leydig cell genes change their expression and association with polysomes in a stage-specific manner in the adult mouse testis†,‡

Estela J. Jauregui,Debra Mitchell,Savanna M. Garza,Traci Topping,Cathryn A. Hogarth,Michael D. Griswold,Estela J Jauregui,Savanna M Garza,Cathryn A Hogarth,Michael D Griswold

DOI: https://doi.org/10.1093/biolre/ioy031

2018-02-02

Biology of Reproduction

Abstract:Abstract Spermatogenesis in mammals occurs in a very highly organized manner within the seminiferous epithelium regulated by different cell types in the testis. Testosterone produced by Leydig cells regulates blood–testis barrier formation, meiosis, spermiogenesis, and spermiation. However, it is unknown whether Leydig cell function changes with the different stages of the seminiferous epithelium. This study utilized the WIN 18,446 and retinoic acid (RA) treatment regime combined with the RiboTag mouse methodology to synchronize male germ cell development and allow for the in vivo mapping of the Leydig cell translatome across the different stages of one cycle of the seminiferous epithelium. Using microarrays analysis, we identified 11 Leydig cell-enriched genes that were expressed in stage-specific manner such as the glucocorticoid synthesis and transport genes, Cyp21a1 and Serpina6. In addition, there were nine Leydig cell transcripts that change their association with polysomes in correlation with the different stages of the spermatogenic cycle including Egr1. Interestingly, the signal intensity of EGR1 and CYP21 varied among Leydig cells in the adult asynchronous testis. However, testosterone levels across the different stages of germ cell development did not cycle. These data show, for the first time, that Leydig cell gene expression changes in a stage-specific manner during the cycle of the seminiferous epithelium and indicate that a heterogeneous Leydig cell population exists in the adult mouse testis.

biology
Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis

E Reaven,L Zhan,A Nomoto,S Leers-Sucheta,S Azhar

Abstract:This study investigates the relationship between the high density lipoprotein (HDL) receptor (scavenger receptors, SR-BI and SR-BII), selective lipoprotein-cholesteryl ester uptake, and testosterone production in Leydig cells of control, hypocholesterolemic and gonadotrophic hormone (hCG) treated rats. Leydig cells from mature control rats show poor efficiency in incorporation of labeled HDL-cholesteryl esters into testosterone, poor selective uptake of lipoprotein lipids overall, and a dramatic reduction of circulating levels of lipoproteins has no apparent effect on testosterone production or expression of intracellular enzymes synthesizing cholesterol. Leydig cells from control rats show minimal levels of SR-BI and SR-BII. However, similarly aged rats treated with hCG for several days undergo changes consistent with hormone-desensitization. Despite the resulting low levels of testosterone production, SR-BI levels are dramatically increased, Leydig cells now efficiently internalize HDL-supplied cholesteryl esters by the selective cholesterol uptake process, and various other cholesterol-sensitive genes of the cells are up-regulated. Only SR-BII expression remains negligible and unchanged throughout this period. It is of interest that Leydig cell SR-BI of hCG-treated rats is localized in surface microvilli, but is present also in an elaborate and complex channel system within the cytoplasm of the cells. In summary, Leydig cells differ from other rat steroidogenic cells in not depending on exogenous lipoprotein-cholesterol during periods of normal steroid hormone production. However, trophic hormone desensitization is accompanied by increased Leydig cell SR-BI expression and increased selective HDL-cholesteryl ester uptake, presumably in preparation for renewed testosterone production.
Differentiation of bone marrow mesenchymal stem cells into Leydig-like cells with testicular extract liquid in vitro

Rong Hua,Fang-Fang Liang,Fang-Qiang Gong,Hua Huang,Yi-Chen Xu,Min He,Yan-Hua Fang,Ya-Shu Wei,Wei-Wei Zhou,Arshad Mehmood,Yi Mo,Zhong Lin

DOI: https://doi.org/10.1007/s11626-024-00902-6

2024-05-03

In Vitro Cellular & Developmental Biology - Animal

Abstract:Differentiation of Leydig cells plays a key role in male reproductive function. Bone marrow mesenchymal stem cells (BMSCs) have emerged as a potential cell source for generating Leydig-like cells due to their multipotent differentiation capacity and accessibility. This study aimed to investigate the morphological and genetic expression changes of BMSCs during differentiation into Leydig-like cells. Testicular extract liquid, which simulates the microenvironment in vivo, induced the third passage BMSCs differentiated into Leydig-like cells. Changes in cell morphology were observed by microscopy, the formation of lipid droplets of androgen precursor was identified by Oil Red Staining, and the expression of testicular specific genes 3β-HSD and SF-1 in testicular stromal cells was detected by RT-qPCR. BMSCs isolated from the bone marrow of Sprague-Dawley (SD) rats were cultured for 3 generations and identified as qualified BMSCs in terms of morphology and cell surface markers. After 14 days of induction with testicular tissue lysate, lipid droplets appeared in the cytoplasm of P3 BMSCs by Oil Red O staining. RT-qPCR detection was performed on BMSCs on the 3 rd , 7 th , 14 th , and 21 st day after induction. Relative expression levels of 3β-HSD mRNA significantly increased after 14 days of induction, while the relative expression of SF-1 mRNA increased after 14 days of induction but was not significant. BMSCs can differentiate into testicular interstitial cells with reserve androgen precursor lipid droplets after induction by testicular tissue lysate. The differentiation ability of BMSCs provides the potential to reconstruct the testicular microenvironment and is expected to fundamentally improve testicular function and provide new treatment options for abnormal spermatogenesis diseases.

cell biology,developmental biology
Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds

Xianwu Chen,Chao Li,Yong Chen,Haitao Xi,Shenzhi Zhao,Leikai Ma,Zhangye Xu,Zhao Han,Junzhao Zhao,Renshan Ge,Xiaoling Guo

DOI: https://doi.org/10.1038/s41419-019-1461-0

2019-03-01

Cell Death and Disease

Abstract:Leydig cells (LCs) play crucial roles in producing testosterone, which is critical in the regulation of male reproduction and development. Low levels of testosterone will lead to male hypogonadism. LC transplantation is a promising alternative therapy for male hypogonadism. However, the source of LCs limits this strategy for clinical applications. Thus far, others have reported that LCs can be derived from stem cells by gene transfection, but the safe and effective induction method has not yet been reported. Here, we report that Leydig-like cells can be derived from human induced pluripotent stem cells (iPSCs) using a novel differentiation protocol based on molecular compounds. The iPSCs-derived Leydig-like cells (iPSC-LCs) acquired testosterone synthesis capabilities, had the similar gene expression profiles with LCs, and positively expressed Leydig cell lineage-specific protein markers LHCGR, STAR, SCARB1, SF-1, CYP11A1, HSD3B1, and HSD17B3 as well as negatively expressed iPSC-specific markers NANOG, OCT4, and SOX2. When iPSC-LCs labeled with lipophilic red dye (PKH26) were transplanted into rat testes that were selectively eliminated endogenous LCs using EDS (75 mg/kg), the transplanted iPSC-LCs could survive and function in the interstitium of testes, and accelerate the recovery of serum testosterone levels and testis weights. Collectively, these findings demonstrated that the iPSCs were able to be differentiated into Leydig-like cells by few defined molecular compounds, which may lay the safer groundwork for further clinical application of iPSC-LCs for hypogonadism.

cell biology
Transplanted Human P75-Positive Stem Leydig Cells Replace Disrupted Leydig Cells for Testosterone Production

Min Zhang,Jiancheng Wang,Chunhua Deng,Mei Hua Jiang,Xin Feng,Kai Xia,Weiqiang Li,Xingqiang Lai,Haipeng Xiao,Ren-shan Ge,Yong Gao,Andy Peng Xiang

DOI: https://doi.org/10.1038/cddis.2017.531

2017-01-01

Cell Death and Disease

Abstract:Previous studies have demonstrated that rodent stem Leydig cell (SLC) transplantation can partially restore testosterone production in Leydig cell (LC)-disrupted or senescent animal models, which provides a promising approach for the treatment of hypogonadism. Here, we isolated human SLCs prospectively and explored the potential therapeutic benefits of human SLC transplantation for hypogonadism treatment. In adult human testes, p75 neurotrophin receptor positive (p75 + ) cells expressed the known SLC marker nestin, but not the LC lineage marker hydroxysteroid dehydrogenase-3 β (HSD3 β ). The p75 + cells which were sorted by flow cytometry from human adult testes could expand in vitro and exhibited clonogenic self-renewal capacity. The p75 + cells had multi-lineage differentiation potential into multiple mesodermal cell lineages and testosterone-producing LCs in vitro . After transplantation into the testes of ethane dimethane sulfonate (EDS)-treated LC-disrupted rat models, the p75 + cells differentiated into LCs in vivo and secreted testosterone in a physiological pattern. Moreover, p75 + cell transplantation accelerated the recovery of serum testosterone levels, spermatogenesis and reproductive organ weights. Taken together, we reported a method for the identification and isolation of human SLCs on the basis of p75 expression, and demonstrated that transplanted human p75 + SLCs could replace disrupted LCs for testosterone production. These findings provide the groundwork for further clinical application of human SLCs for hypogonadism.

Integration of Signage Information into the Web Environment

A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors

High Throughput scRNA-Seq Provides Insights Into Leydig Cell Senescence Induced by Experimental Autoimmune Orchitis: A Prominent Role of Interstitial Fibrosis and Complement Activation

Stem Leydig cells support macrophage immunological homeostasis through mitochondrial transfer in mice

Androgen-Forming Stem Leydig Cells: Identification, Function and Therapeutic Potential

(063) The Role of Leptin as a Testicular Immune Microenvironment Modulator and Leydig Stem Cell Function

Calcific aortic valve disease: new concepts.

NR2F2 regulation of interstitial to fetal Leydig cell differentiation in the testis: insights into differences of sex development

Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction

Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency

Effects of aging and macrophages on mice stem Leydig cell proliferation and differentiation in vitro

An autofluorescence-based isolation of Leydig cells for testosterone deficiency treatment

The Cell Fates of Intermediate Cell Population in Prostate Development

Single-Cell RNAseq Resolve the Potential Effects of LanCL1 Gene in the Mouse Testis

Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults.

Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction

Leydig cell genes change their expression and association with polysomes in a stage-specific manner in the adult mouse testis†,‡

Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis

Differentiation of bone marrow mesenchymal stem cells into Leydig-like cells with testicular extract liquid in vitro

Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds

Transplanted Human P75-Positive Stem Leydig Cells Replace Disrupted Leydig Cells for Testosterone Production